Illness	Number of cases
Leiomyoma of uterus - Intramural leiomyoma of uterus (D25.1)	56
Malignant neoplasm of breast (C50.8)	43
Malignant neoplasm of breast (C50.4)	42
Malignant neoplasm of breast (C50.2)	22
Carcinoma in situ of breast (D05.1)	22
Malignant neoplasm of breast (C50.5)	21
Leiomyoma of uterus - Leiomyoma of uterus unspecified (D25.9)	19
Benign neoplasm of ovary (D27)	18
Female genital prolapse - Incomplete uterovaginal prolapse (N81.2)	16
Malignant neoplasm of breast (C50.3)	12

Top 10 treatments

Treatment	Number
Taking a tissue sample (biopsy) of other organs or tissues through the skin, guided by imaging procedures such as ultrasound (1-494.32)	161
X-rays of the breast (3-100.1)	144
X-rays of the breast (3-100.0)	117
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.11)	105
Imaging procedure to show the lymphatic system by means of radioactivity (scintigraphy) (3-709.00)	84
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a0)	79
Surgical removal and destruction of diseased uterine tissue (5-681.68)	41
Surgical removal of a fallopian tube (5-661.62)	28
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.90)	28
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a1)	28

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
79	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
60	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
60	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre phase III/IV studies
Doctoral supervision
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities